LEADER 00960nam0-2200325---450- 001 990008348530403321 005 20060620163658.0 010 $a88-15-10620-0 035 $a000834853 035 $aFED01000834853 035 $a(Aleph)000834853FED01 035 $a000834853 100 $a20060620d2005----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $a----a---001yy 200 1 $aCesure e tornanti della storia contemporanea$fa cura di Paolo Pombeni$gcon la collaborazione di Marzia Maccaferri 210 $aBologna$cil Mulino$dc2005 215 $a303 p.$d22 cm 225 1 $aItinerari$iStoria 320 $aBibliografia: p. 291-295 702 1$aPombeni,$bPaolo$f<1948- > 702 1$aMaccaferri,$bMarzia 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008348530403321 952 $aN01.242$b149/DE$fDECTS 959 $aDECTS 996 $aCesure e tornanti della storia contemporanea$968965 997 $aUNINA LEADER 04281nam 22005535 450 001 9910427857903321 005 20250610110558.0 010 $a3-030-57949-2 024 7 $a10.1007/978-3-030-57949-4 035 $a(CKB)5340000000066937 035 $a(DE-He213)978-3-030-57949-4 035 $a(MiAaPQ)EBC6424512 035 $a(PPN)252517563 035 $a(MiAaPQ)EBC29092568 035 $a(EXLCZ)995340000000066937 100 $a20201212d2020 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Immunology $eCancer Immunotherapy for Organ-Specific Tumors /$fedited by Nima Rezaei 205 $a2nd ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (XXX, 581 p. 34 illus., 30 illus. in color.) 311 08$a3-030-57948-4 327 $aSpecific Organ Tumors: General Considerations On Immunotherapy -- Vaccination Of Human Solid Tumors: Recent Progress In The Clinical Setting -- Immunotherapy For Pediatric Solid Tumors -- Immunopathology Of Hematological Cancers And Immunotherapy Of Leukemia And Multiple Myeloma -- Immunopathology Of Lymphoma And Immunotherapy Of Hodgkin's Disease And Non-Hodgkin's Lymphoma -- Cancer-Testis Antigens As Targets For The Immunotherapy Of Hematological Malignancies -- Tumor Immunology And Immunotherapy Of Gastrointestinal Tract Cancers -- Immunology And Immunotherapy Of Colorectal Cancer -- Immunopathology Of Hepatobiliary Tumors And Immunotherapy Of Liver Cancers -- Immunology And Immunotherapy Of Pancreatic Tumors -- Immunology Of Cutaneous Tumors And Immunotherapy For Melanoma -- Immunopathology Of Head And Neck Tumors And Immunotherapy Of Squamous Cell Carcinoma -- Immunopathology And Immunotherapy Of Oral Cancers -- Immunopathology Of Bone And Connective Tissue Cancers And Immunotherapy Of Sarcomas -- Immunopathology Of Central Nervous System Cancers And Immunotherapy Of Brain Tumors -- Immunology And Immunotherapy Of Pulmonary Tumors -- Immunopathology Of Urinary System Cancers And Immunotherapy Of Renal And Bladder Cancers -- Immunopathology Of Cancers Of Male And Female Genitalia Organs And Immunotherapy Of Cervical And Prostate Cancer -- Immunology And Immunotherapy Of Ovarian Cancer -- Revisiting Immunology For Breast Cancer -- Immunology And Immunotherapy Of Graft Versus Host Disease. 330 $aThis book explains the immunology of organ-specific malignancies and discusses novel immunotherapy strategies for their treatment. Since the first, very successful edition of the book was published in 2015, a number of entirely new chapters have been included. The range of cancers considered has accordingly been extended, with coverage of the latest immunotherapy approaches for skin cancers, ocular malignancies, endocrine malignancies, cardiac cancers, vascular cancers, and HPV-associated cancers. In addition, the original chapters have been updated to document the latest advances in immunotherapy for pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, bone tumors, CNS tumors, lung cancer, genitourinary tract tumors, and breast cancer, among others. The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and bench to bedside immunotherapy. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors will be of special value to clinical immunologists, hematologists, and oncologists. . 606 $aOncology 606 $aInternal medicine 606 $aImmunology 606 $aOncology 606 $aInternal Medicine 606 $aImmunology 615 0$aOncology. 615 0$aInternal medicine. 615 0$aImmunology. 615 14$aOncology. 615 24$aInternal Medicine. 615 24$aImmunology. 676 $a616.994061 702 $aRezaei$b Nima 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910427857903321 996 $aCancer Immunology$91760493 997 $aUNINA